1 ( concentrated electrolytes ) ก
|
|
- Georgia Briggs
- 5 years ago
- Views:
Transcription
1 ก ก HAD 1 ( concentrated electrolytes ) ก ก ก ( ) ก ก ก ก 2 ก ก ก (Patient care unit) ก ก ก ก ( Hemodialysis ) ก ก ก ก ก ก stock card ก ก ( High Alert Drug (HAD)) ก ก ก ก (Pharmacy and Therapeutic Committee (PTC)) ก ( High Alert Drug (HAD)) ก ก / ก ก ก ก ก ก ก ( High Alert Drug(HAD) ก ก ก ก ก 17 ก 160 ก ก 1. ADRENERGIC AGONISTS, INJECTION Epinephrine (Adrenaline), Norepinephrine, Dopamine, Dobutamine 2. ADRENERGIC ANTAGONISTS,INJECTION Labetalol (Avexa ) 3. ANESTHETIC AGENTS Ketamine (Calypsol ), Propofol (Anepol, Fresofol ), ETOMIDATE, ISOFLURANE (Forane ), SEVOFLURANE (Sevorane ), THIOPENTONE (Pentothal ) 4. ANTIARRYTHMIC AGENTS LIDOCAINE (Charlocaine, Drocanil-A ), AMIODARONE (Cordarone ), ADENOSINE (Adenocor ), DILTIAZEM (Herbesser ) 5. ANTICOAGULANTS, THROMBOLYTIC/ FIBRINOLYTIC AGENTS HEPARIN (HEPARIN- LEO ), ENOXAPARIN SODIUM (CLEXANE ), NADROPARIN (FRAXIPARIN ), FONDAPARINUX (ARIXTRA ), WARFARIN ORAL (BEFARIN, ORFARIN ), ALTEPLASE (ACTILYSE ), STREPTOKINASE (STREPTASE ) 6. CYTOTOXIC AGENTS BEVACIZUMAB, BICALUTAMIDE, BLEOMYCIN, CARBOPLATIN, CETUXIMAB, CHLORAMBUCIL, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, DOXORUBICIN, DOCETAXEL, EPIRUBICIN, ETOPOSIDE, FLUOROURACIL, GEFITINIB, GEMCITABINE, HYDROXYUREA, IDARUBICIN, IFOSFAMIDE, IRINOTECAN, LETROZOLE, MEDROXYPROGESTERONE ACETATE, MEGESTROL ACETATE, MELPHALAN, MERCAPTOPURINE, METHOTREXATE oral, IV, Non- 1
2 oncologic use, MITOMYCIN, OXALIPLATIN, PACLITAXEL, TAMOXIFEN, VINBLASTIN, VINCRISTINE 7. CONCENTRATED ELECTROLYTES POTASSIUM CHLORIDE 20 meq/10ml, INJECTION, DIPOTASSIUM PHOSPHATE 20 meq/20 ml INJECTION, MAGNESIUM SULFATE 10%, INJECTION ( 1 gm ) SODIUM CHLORIDE 3% INJECTION, CALCIUM GLUCONATE 10% INJECTION, 7.5 % SODIUM BICARBONATE 50 ML, CARDIOPLEGIC SOLUTION 8. 50%GlUCOSE for INJECTION 50%GlUCOSE for INJECTION 20 ml, 50 ml 9. DIALYSIS SOLUTION DIALYSIS SOLUTION Peritoneal and hemodialysis 10. EPIDURAL OR INTRATHECAL MEDICATIONS LEVOBUPIVACAINE (CHIROCAINE ), BUPIVACAINE SPINAL/ EPIDURAL (MARCAINE ) 11. HYPOGLYCEMIC AGENTS AND INSULIN GLIBENCLAMIDE (BENCLAMIDE, DAONIL, GLUCOVANCE 2.5/500,5/500), GLIPIZIDE (DIPAZIDE, MINIDIAB ), GLICLAZIDE (DIAMICRON, DIAMICRON MR, DIANID, GLIZID-M ), GLIMEPIRIDE (AMARYL, AMARYL-M ), REPAGLINIDE (NOVONORM ), Insulin lispro (Humalog ), Regular Insulin (Humulin - R ), Insulin isophane suspension (Humulin- N ), Insulin glargine (Lantus ), Insulin detemir (Levemir ), Insulin aspart 30% (Novo Mix 30 HM ), Insulin lispro protamine suspension (Humalog Mix 25 ), Insulin 70/30 (Humulin70/30, Mixtard 30 HM ) 12. INOTROPIC MEDICATIONS Digoxin, Milrinone 13. MODERATE SEDATION AND NARCOTICS/ OPIATES MIDAZOLAM IV (DORMICUM ), DIAZEPAM (DIAPINE )10 mg IV, CHLORAL HYDRATE ORAL, MORPHINE SULFATE IV, Oral, FENTANYL IV, Transdermal (Durogesic ), PETHIDINE 14. NEUROMUSCULAR BLOCKING AGENTS SUCCINYL ( SICCUM ASTA ) 500 MG INJECTION, ATRACURIUM (TRACIUM ), PANCURONIUM (PAVULON ), ROCURONIUM (ESMERON ), CISATRACURIUM (NIMBEX ) 15. CONTRAST AGENT IOPROMIDE (ULTRAVIST ), IODIXANOL (VISIPLAQUE ), IOPAMIDOL (IOPAMIRO-300,370 ), IOXITHALAMATE (TELEBRIX ) 16. TOTAL PARENTERAL NUTRITION Oliclinomel N4-550E 2000 ml, N4-550E 1500 ml, N E 2000 ml, Kabiven Peripheral 1000 kcal (1440 ml),1400 kcal (1920 ml), Aminoleban 8% inj. 500 ml, 10% AMINOSOL SOLUTION 500 ML, Kidmin inj. 200 ml, 10%Lipovenos /10%Intralipid, 20%Lipovenos / 20 % Intralipid, NEO-AMIYU 200 ml, 6.5% VAMINOLACT 100 ML, 7% NEPHROSTERIL, ADDAMEL*N 10 ml 17. OTHER MEDICATION NITROGLYCERIN/ GLYCERYL TRINITRATE (NITROCINE ), SODIUM NITROPRUSSIDE, MISOPROSTAL ORAL (CYTOTEC ), OXYTOCIN 2
3 (SYNTOCINON ), Sterile water for injection, inhalation, and irrigation in containers of 100 ml or over ( Concentrated electrolytes ) Potassium chloride (KCL) กก ก 2 meq/ml, Potassium phosphate, Sodium chloride ( NaCl ) กก 0.9 % Magnesium sulfate ( MgSO4) ก 1 gm ( Concentrated electrolytes ) ก - Potassium chloride (KCL)(15%=20mEq/10ml ) injection - Dipotassium Phosphate ( K2HPO4 ) 20mEq/20ml injection - Sodium Chloride ( NaCl ) 3% injection 500 ml - Magnesium sulfate 10% ( 10 ml ) = 1 gram injection - Calcium gluconate 10 % injection - 7.5% Sodium bicarbonate - Hemodialysis ก Pheno A LC 1.75 W/Glu K=3 - Pheno A LC 2 W/Glu K=3 - Pheno A LC 2.5 W/Glu K=2 - Pheno A LC 2.5 W/Glu K=3 - Pheno A LC 3.5 W/Glu K=2 - Pheno B ก ก 1. ก 1.1 ก ก ก ก 1.2 ก ก ก ก ก 1.3 (ready-to-administer) (ready-to-use) ก 2. ก ก ก 2.1 ก ก ก ก ก ก ก 3
4 2.2 ก ก ก ก ก ก ก / ก ก ก, ก ก ก 2.3 Sticker ก ก ก 2.4 ก ก กก inchage ก กก 3. ก 3.1 ก 3.2 ก ก ก MoSO 4 ก MgSO ก ก / ก ก ก ก ก ก ก ก ก 4.1 location double check ก ก ก ก 2 ก ก Drug Related Problems (DRPs) 4.3 ก ก ก ก 4.4 ก ก ก ก ก ก ก ก ก 4.5 ก 1 ก ก 5. ก 5.1 double check ก ก ก 6 R ก ก ก ก ก ก กก ก double check ก ก ( High Alert Drug (HAD)) ก ก ก High Alert Drugs 5.4 ก ก ก กก ก ก ก 6. ก ก ก กก 4
5 6.1 ก กก ก ก nurse note 6.2 ก ก ก ก ก 6.3 ก 7. ก ก 7.1 ก ก High Alert Drug 7.2 ก High Alert Drug 7.3 ก High Alert Drug ก ก 5
UP Health System Marquette Medication Guideline High Alert Drugs
1 ALTEPLASE SOLR 100 MG ACTIVASE 305010 50242008527 TRUE ALTEPLASE SOLR 50 MG ACTIVASE 305008 50242004413 TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV 305035 63323061609 TRUE AMIODARONE INJ 50 MG/ML CORDARONE
More informationConflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations
Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives
More informationCritical Care Standard Infusion Concentrations
Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in
More informationDon't forget to see our PharmaTags: Sterile Medication Labels at
PharmaTags: Anaesthesia Roll Labels Order Form Toll Free: 1 888 299 2661 PRICING: 10 Rolls Same Medication Label=$5.75/Roll or $57.50 Box Mix and Match 10 Rolls= $6.25/Roll or $62.50/Box Minimum Order
More informationChecklist/Action Plan for the Management of High-Alert Medications
... Attachment 1.G Checklist/Action Plan for the Management of High-Alert Medications (adapted from High-Alert Medications: Safeguarding Against Errors by Michael Cohen and Charles Kilo, In: Medication
More informationWest of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting
West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial
More informationCOST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!
UICCEMLCostingScenarios BackoftheEnvelope Calculations PreparedforWorkingGroupSession:19621November2014,Geneva MethodsSummary We have chosen a conservative approach, calculating cost per vial. We have
More informationANESTHESIA DRUG REVIEW
ANESTHESIA REVIEW CAPA S 39 TH ANNUAL CONFERENCE PALM SPRINGS OCTOBER 10, 2015 ROBERT F. KOPEL, MD, FACP, FCCP HOAG HOSPITAL CARDIAC ANESTHESIOLOGIST ASSISTANT CLINICAL PROFESSOR UCLA SCHOOL OF MEDICINE
More informationNOTICES DEPARTMENT OF HEALTH
NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [42 Pa.B. 4229] [Saturday, July 7, 2012] Under 28 Pa. Code 1005.11(b) (relating to drug use, control and security), the following
More informationAdult Critical Care Intravenous Infusions Titration Protocol
Adult Critical Care Intravenous Infusions Protocol Nursing staff to titrate drip to achieve goal ordered by provider in assigned time intervals. Amiodarone (Pacerone ) Argatroban Non-heparin anticoagulant
More informationExhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A
More informationGuidelines for the Use of Anti-Emetics with Chemotherapy
Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting
More informationMASCC Guidelines for Antiemetic control: An update
MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,
More informationHIGH ALERT MEDICATIONS
PAGE: 1 of 12 1. PURPOSE This policy describes minimum standards to assure that sites, departments, and areas in Aurora Health Care that handle high risk medications have considered the risk of error associated
More informationFrom the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,
From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document
More informationThe following are J Code requirements
The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based
More informationBT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.
0542-02 Adenosine 6mg, 2ml Vial (limited qty on hand) 0301-67 Adenosine 6mg, 2ml LL Syringe 0651-04 ADENOSINE 12MG 4ML SDV 0301-68 Adenosine 12mg, 4ml LLSyringe early early 0302-66 Amiodarone 150mg, 3ml
More informationthe generation of arcomed Where functionality meets safety!
the generation of arcomed Where functionality meets safety! «What do I want?» asks the mind desire Immanuel Kant «What s the point?» asks the faculty of judgement +function Immanuel Kant «What s the result?»
More informationCustomer Service: Shop online at
Effective May 1, 2017 Item Number Changes for Pharmaceuticals Due to changes in regulatory requirements, effective May 1, 2017, some of our pharmaceuticals' units of sale will change. The table below outlines
More informationIV Medication Drip Chart
IV Medication Drip Chart Index Summary chart 2 IV Medication drip chart Amiodarone 2 Atracurium 2, 5 Cisatracurium 2, 5 Dexmedetomidine 2 Dobutamine 2, 6 Dopamine 2, 6 Epinephrine 2, 7 Esmolol 2, 7 Etomidate
More informationUTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH
Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the
More informationEmetogenicity level 1. Emetogenicity level 2
Emetogenicity level 1 15 mins Pre-Chemo Maxalon 10mg po During chemo and Post Chemo 3 days Maxalon10mg po 8 hourly Increase Maxalon 20mg po 8 hourly Change to Cyclizine 50mg po 8 hourly 3 days If nausea
More informationICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced
ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA
More informationObjective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.
WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black
More informationCHAPTER II DRUG INDUCED PULMONARY DISEASES. BY J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY
CHAPTER II DRUG INDUCED PULMONARY DISEASES BY J. jayasutha lecturer department of pharmacy practice Srm college of pharmacy SRM UNIVERSITY Drug Induced Pulmonary Disorders Is almost always a diagnosis
More informationBlanchard Valley Hospital Pharmacy Code Blue Overview
Blanchard Valley Hospital Pharmacy Code Blue Overview Adapted from Gary Spanik, RPh Edited by Kate Reeves, Pharm D, RPh Jon Manocchio, Pharm D, RPh Pharmacist Responsibilities Be aware of basic ACLS tenets
More informationGUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION
GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,
More informationGuidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients
Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For
More informationOur mission is better health care outcomes.
Our mission is better health care outcomes. Purity Product Catalog December 2018 nephronpharm.com 1 (844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic respiratory and
More informationVI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic
More informationChapter / Section / Drug
2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone
More informationCHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A
CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory
More informationLIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.
LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml
More informationDrug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)
Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension
More informationDME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018
G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,
More informationDME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019
G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,
More informationDOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days
Last updated Oct 17, 2018 Tumour Group Protocol Number Protocol Name on NCCP website Breast 200 Trastuzumab (IV) Monotherapy 21 days 201 Trastuzumab (IV) Monotherapy 7 days 202 DOCEtaxel Monotherapy 100mg/m2
More informationRelease of the 2017/18 Invitation to Tender
2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s
More informationProduct Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved
Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole
More informationProtocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249
Last updated Feb 9, 2018 Revision due Protocol Name on NCCP website Tumour Group Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Two Day Etoposide CISplatin
More informationProtocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy
Last Updated 22-Feb-18 Date of last update Protocol Number Tumour Group Protocol Name on NCCP website 22/02/2018 221 Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy 249 Gynaecology Intrathecal
More informationHelp Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes
Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Where positive identification meets safe, efficient patient care. Improve Patient Safety with Accurate Medication Labeling
More informationRajasthan Medical Services Corporation Limited, Jaipur
Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV
More informationNorth Carolina College of Emergency Physicians Standards for EMS Medications and Skills Use
. The baseline medications and skills required in all systems and Specialty Care Transport Programs) with EMS personnel credentialed at the specified level. S. The equipment required in all Specialty Care
More informationLook-Alike/Sound-Alike (LASA) Medication Chart
Look-Alike/Sound-Alike (LASA) Medication Chart Last Revised: August 2018 Lipid based amphotericin products amphotericin B lipid complex (Abelcet ) amphotericin B liposomal (Ambisome ) Conventional forms
More informationOur mission is better health care outcomes.
Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog March 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic
More informationJ1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364
G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288
More informationELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY
ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed
More informationOFFERâ S INJECTABLES
A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary
More informationDavis s Drug Guide Scavenger Hunt 15 th Edition
Davis s Drug Guide Scavenger Hunt 15 th Edition This handout is designed to assist you in locating information in the Davis s Drug Guide. Take advantage of the many resources in this text!! Locate the
More informationBT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.
September 28, 2018 Pharmaceutical Backorder Report BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description 0542-02 Adenosine 6mg, 2ml Vial (limited
More informationOur mission is better health care outcomes.
Our mission is better health care outcomes. Efficiency Purity Efficacy Product Catalog April 2019 nephronpharm.com 1(844) 224-2225 Nephron Pharmaceuticals Corporation is a leading manufacturer of generic
More informationAdult Intravenous Systemic Anticancer Therapy (SACT) Section A. SUMMARY of SCHEME QIPP Reference
CA2 Nationally standardised Dose banding for Adult Intravenous Anticancer Therapy (SACT) Scheme Name CA2: Nationally Standardised Dose Banding for Adult Intravenous Systemic Anticancer Therapy (SACT) Section
More informationFOR A HIGHER DEGREE OF CONFIDENCE
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS. > Introduction Manufacturing specialized products in a pharmaceutical manufacturing environment has a specific set of requirements
More informationPatient 1: Patient 2:
Appendix A Compiled by Dr. Raymond Ngeh and Dr. Robert Luk Clinical notes and PET/CT scan images of eleven patients: 1. Middle age woman has cancer of the pancreas in the body of the gland. After just
More informationMedication Safety and High Alert Medications
Medication Safety and High Alert Medications Objectives At the completion of this presentation participants should: 1. Be able to identify what a high alert medication is and what medications are considered
More informationGuideline Update on Antiemetics
Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction
More informationSCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders
1.0 Introduction The (SCI) is a not-for-profit collaboration between the Hospital for Sick Children (SickKids), Toronto, Canada, and seven Caribbean health care institutions across six countries that strive
More informationPharmacology in Critical Care: What are We Giving?
1 Pharmacology in Critical Care: What are We Giving? J. Brady Scott, MS, RRT ACCS Assistant Professor Respiratory Care Rush University Medical Center 1 Conflict of Interest I disclose affiliations with
More information1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation.
Alberta Regulation 18/2005 Cancer Programs Act AMENDMENT REGULATION Filed: February 22, 2005 For information only: Made by the Minister of Health and Wellness (M.O. 9/2005) on February 17, 2005 pursuant
More informationPrimary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site
Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or
More informationVasco OP Underglove Sterile Surgical and Protective Gloves
data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Underglove gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical
More information1 ml) (100 x. 10 ml)
SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity
More informationSection 8.4 Special Dilutions
Section 8.4 Special Dilutions Terminology: Diluent: Pediatric Compound Sterile Preparations (CSPs): Special Dilutions: Calculating Special Dilutions: Ratio-Proportion vs Dimensional Analysis Part A Calculating
More informationDRUG ALLERGIES WT: KG
DRUG AND TREATMENT Acute Diabetic Ketoacidosis Condition/Status ***(NOTE)*** For purpose of this DKA Regimen, DKA is considered clear only when the CO2 is GREATER than 18 meq/l and the anion gap is LESS
More informationASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use ASSESSMENT OF THE PAEDIATRIC NEEDS ANAESTHESIOLOGY London, October 2006 Doc. Ref: EMEA/405166/2006 DISCLAIMER The Paediatric Working Party
More informationMEDICAL NECESSITY GUIDELINE
PAGE: 1 of 10 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
More informationActive Pharmaceutical Ingredient (API) List List Updated March 1st, 2019
5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin
More informationAPPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer
APPHON/ROPPHA Guideline for the Prevention and Management of Chemotherapy Induced Nausea and Vomiting in Children with Cancer 5850/5980 University Avenue, PO Box 9700, Halifax, N.S. B3K 6R8 PEDIATRIC HEMATOLOGY/ONCOLOGY
More informationChapter 2 ~ Cardiovascular system
Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection
More informationLIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT
LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion
More informationClinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text]
Clinical Manual Part 4 Standard Drug List Version 8.1 July 2018 [Type text] Royal Flying Doctor Service Western Operations 3 Eagle Drive, Jandakot Airport, Western Australia 6164 T 61-8-9417 6300 F 61-8-9417
More informationSELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS
SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS Manufacturing specialized products in a pharmaceutical
More informationNorth Carolina Medical Board Approved Medications for Credentialed EMS Personnel
North Carolina Medical Board Approved Medications for Credentialed EMS Personnel EMS personnel at any level who administer medications must do so within an EMS system that provides medical oversight. Personnel
More informationAdverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and
35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting
More informationAn introduction to the Essential Medicines concept: balancing innovation with public health priorities
An introduction to the Essential Medicines concept: balancing innovation with public health priorities WHO HQ, Geneva 11 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the Selection and
More informationDRUG EXTRAVASATION. Vesicants. Irritants
DRUG EXTRAVASATION Vesicants Irritants Vesicants Antineoplastic drugs Amsacrine Dactinomycin Daunorubicin Docetaxel (rare) Doxorubicin Epirubicin Idarubicin Mechlorethamine Mitomycin Oxaliplatin (rare)
More informationMedical Therapies in Ovarian Cancer The Arabic Perspectives. Mezghani Bassem -Tunisia
Tunisian Health System: Social Welfare with a Public insurance for all citizens including Indigent persons. (± Additional private insurance) Choice: Public Hospital/Private Clinics (Indigents Public H)
More informationOriginal Date of issue: 01/11/2005 Last Reviewed: 01/05/2011 Version:4 Page 1 of 7
Original Date of issue: 01/11/2005 Last eviewed: 01/05/2011 Version:4 Page 1 of 7 15: Anaesthesia 15.1 General anaesthesia 15.1.1 Intravenous anaesthesia Etomidate Injection (20mg/10ml) Ketamine Injection
More informationNorth Carolina Medical Board Approved Medications for Credentialed EMS Personnel
North Carolina Medical Board Approved Medications for Credentialed EMS Personnel EMS personnel at any level who administer medications must do so within an EMS system that provides medical oversight. Personnel
More informationVasco OP Free Sterile Surgical and Protective Gloves
DATA SheeT EN 374:2003 EN 374:2003 AQl 0.65 B. Braun Melsungen AG confirms that Vasco OP Free gloves comply with the following standards and directives: ec certificates AnD APPlieD STAnDArDS Medical device
More informationCURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES
CURRENT DRUG SHORTAGES (through February 22, 2013) CRITICAL SHORTAGES Acetylcysteine Inhalation Analgesic Buprenorphine Caffeine and Ergotamine Acyclovir Meperidine Injection Adenosine Amino Acid Products
More informationVasco OP Sensitive Sterile Surgical and Protective Gloves
data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Sensitive gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical
More informationActive Pharmaceutical Ingredient (API) List List Updated 03/08/2018
5-Fluorouracil HPLC/ UHPLC Yes USP 4017 30 5mL 2 7-keto DHEA HPLC/ UHPLC Yes Medisca 4258 180 5mL 1 Acetaminophen HPLC/ UHPLC Yes USP 4406 5mL 2 Acetylcysteine HPLC/ UHPLC Yes USP 4255 60 5mL 1 Adenosine
More informationVMG Pharmaceuticals Pvt. Ltd.
S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets
More informationCANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs
CANCER PREVENTION AND ACCESS TO MEDICINES Gracemarie Bricalli ESMO Head of International Affairs ESMO s 2020 Vision: Access to cancer care ESMO s 2020 vision statement recognises that progress in the management
More informationUNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE
UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Subject: Hazardous Drugs and Chemicals IAC.657-7.8(10) (Formerly High Alert and Hazardous Medications MM.01.01.03) (Formerly
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationCOVERSYL 5 3,730 PERINDOPRIL COVERSYL PERINDOPRIL COVERSYL PLUS 4,125 PERINDOPRIL+INDAPAMIDE غير متوفر CLEXANE ,010 ENOXAPARIN
مالحظات التركيب العلمي السعر الدواء األجنبي SERETIDE-500 7,425 FLUTICASONE+ SALMETEROL SERETIDE-100 4,265 FLUTICASONE+ SALMETEROL ATROVENT INHALER 1,970 IPRATROPIUM IMURAN 2,500 AZATHIOPRINE VENTOLIN DISKUS
More informationMedication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC
Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication
More information1. Purpose Documentation Description.1 4. References 8 5. Cross-References.8 6. Development of the guideline.8
CLINICAL GUIDELINE For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: Oncology/Haematology Unit (excluding Paediatrics) Oncologists, Haematologists,
More informationAntiemetics: Guidelines, Interactions and more.
Antiemetics: Guidelines, Interactions and more. Chemotherapy-induced side effects -the patient s view Loss of hair The thought of coming for chemo Affects family/partner Affects work/home duties Jude Lees
More informationModule 8: Practice Problems
Module 8: Practice Problems 1. Convert a blood plasma level range of 5 to 20 µg/ml of tobramycin (Z = 467.52) to µmol/l. 5 µg/ml = 10.7 µmol/l 20 µg/ml = 42.8 µmol/l 2. A preparation contains in each milliliter,
More informationGuideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients POGO Antineoplastic Induced Nausea and Vomiting Guideline Development Panel: L.
More informationProcedure. AREAS OF RESPONSIBILITY All UNMH staff.
Page 1 of 8 Title: High Alert, and Look-Alike Sound-Alike Medications Applies To: UNM Hospitals Responsible Department: Pharmacy Procedure Patient Age Group: ( ) N/A (X) All Ages ( )Newborns ( )Pediatric
More informationMiracalus Pharma Pvt Limited
Dealers in Vaccines, TPN, Blood products and All Anti-Cancer Drugs Miracalus Pharma Pvt Limited ANTI CANCER - Injections ING CISPLATIN 10MG CISTEEN 1 VIAL ING CISPLATIN 50MG CISTEEN 1 VIAL INJ 5 FLURO
More informationWHO Model List (revised April 2002)
Essential Medicines Explanatory Notes The complementary list presents essential medicines for priority diseases which are efficacious, safe and cost-effective but not necessarily affordable, or for which
More informationZzbeacon,Zayna [MR ]
AALL1131 INTERIM MAINTENANCE, HR-ALL, ARM B, HD MTX Properties Cycle 1 9/27/2012 through 11/28/2012 (63 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release CBC and differential Release Release
More information